Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects
Condition(s):Aneurysmal Subarachnoid HemorrhageLast Updated:August 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Aneurysmal Subarachnoid HemorrhageLast Updated:August 31, 2023Completed
Condition(s):Subarachnoid Hemorrhage, AneurysmalLast Updated:July 26, 2018Terminated
Condition(s):Aneurysmal Subarachnoid Hemorrhage (aSAH)Last Updated:February 28, 2024Recruiting
Condition(s):Stroke; Mild Cognitive ImpairmentLast Updated:October 14, 2010Unknown status
Condition(s):Oral Nimodipine; Milrinone; Vascular Spasm After Traumatic SubarachnoidhaemorrhageLast Updated:May 25, 2022Completed
Condition(s):InfertilityLast Updated:March 8, 2019Terminated
Condition(s):DepressionLast Updated:September 29, 2016Terminated
Condition(s):Cerebral InfarctionLast Updated:May 1, 2018Completed
Condition(s):Cocaine-Related DisordersLast Updated:February 24, 2017Completed
Condition(s):Subarachnoid HemorrhageLast Updated:June 13, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.